Dibucaine base en es it fr

Dibucaine base Brand names, Dibucaine base Analogs

Dibucaine base Brand Names Mixture

  • No information avaliable

Dibucaine base Chemical_Formula

C21H27NO

Dibucaine base RX_link

No information avaliable

Dibucaine base fda sheet

Dibucaine_base FDA

Dibucaine base msds (material safety sheet)

Dibucaine_base MSDS

Dibucaine base Synthesis Reference

No information avaliable

Dibucaine base Molecular Weight

309.445 g/mol

Dibucaine base Melting Point

No information avaliable

Dibucaine base H2O Solubility

No information avaliable

Dibucaine base State

Solid

Dibucaine base LogP

4.86

Dibucaine base Dosage Forms

Tablets for oral administration (25 mg, 50 mg)

Dibucaine base Indication

For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.

Dibucaine base Pharmacology

No information avaliable

Dibucaine base Absorption

Well absorbed from gastrointestinal tract following oral administration.

Dibucaine base side effects and Toxicity

Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).

Dibucaine base Patient Information

No information avaliable

Dibucaine base Organisms Affected

Humans and other mammals